JAMA Network Home
Sign In
Viewpoint

Direct-to-Consumer Tests for Chlamydia and Gonorrhea

JAMA 10.1001/jama.2025.20617

November 17, 2025 at 11:00 AM EST

Read the full article

This Viewpoint discusses the disadvantages of direct-to-consumer home tests for chlamydia and gonorrhea in terms of the goals of public health authorities related to the management and control of sexually transmitted diseases.

Corresponding Author: M. Jacques Nsuami, MD, MPH, Section of Infectious Diseases, Department of Internal Medicine, School of Medicine, Louisiana State University Health Sciences Center, 2021 Perdido St, Room 4337, New Orleans, LA 70112 (mnsuam@lsuhsc.edu).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2025.20617?utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_term=111725

Copy to clipboard

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.

Editor's Picks